Delivery Order SPE2DB24D1205-SPE2DB25FCVER

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Potassium Citrate ER 10 MEQ tablets. The $1,566.27 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,055.48, is for the delivery of 4564520367 POTASSIUM CIT-CITRIC ACID SOLN 473ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The period of performance runs through May 8, 2024. This award is not associated with a set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.67 firm fixed-price delivery order is for the supply of POTASSIUM CL 10% (20MEQ/15ML) CUP UD 15ML medical products, with a performance period ending on June 11, 2024. The contract award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,192.10 for the supply of potassium chloride 10 MEQ/100 mL solution. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 26, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $2,058.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4557842594 POTASSIUM CL ER 10 MEQ TABLET 1000S, with a completion date of July 20, 2022. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 14, 2021. The $3,169.21 firm fixed-price delivery order is for the supply of POTASSIUM CL 20 MEQ PACKET 30S medical products. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $2,413.80. The contract provides 4,561,985,737 potassium chloride extended-release 20 milliequivalent tablets in 100-count bottles. There is no set-aside designation, indicating this was an open competition. Amerisourcebergen, a major pharmaceutical distributor, plays a critical role in supplying medical...
This federal contract award, valued at $2,866.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB24FQZ54) for the supply of 4565097121 - Potassium Chloride Extended Release 20 MEQ Tablets in 500-count packages. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,544.00 firm-fixed-price delivery order is for the supply of 4565123260 - Potassium Chloride Extended Release 10 MEQ Capsules in 500-count bottles. The contract has a completion date of July 12, 2024 and was awarded on July 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and its healthcare programs. The $1,632.76 firm-fixed-price delivery order, with a completion date of February 12, 2024, includes the delivery of potassium chloride extended-release tablets. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVER
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,837.41, is a delivery order for the supply of 4567677623 ! POTASSIUM CITRATE ER 10 MEQ TB UU 100S. The contract has no set-aside designation, indicating open competition.

Amerisourcebergen is the prime contractor and holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/29/25, 1:00 AM